The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis Title

Rama Hussein, Imad Aboukhamis

Authors

Biochemistry and Biophysics Reports

 Source title
2405-5808  ISSN 
Q3


http://creativecommons.org/licenses/bync-

nd/4.0/
link
Our study aims to detect whether the serum RANKL could be a novel potential biomarker for activity and diagnosis of rheumatoid arthritis (RA). It included fifty-eight of RA patients and thirty of equal age and sex matched controls. Disease activity was determined by using DAS28-ESR. Serum Levels of RANKL were assayed by ELISA and compared with parameters such as ESR, CRP, Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). The serum RANKL levels were higher in RA patients compared to controls. There was an increase in its levels mean among post-menopausal patients compared to post-menopausal healthy group. RANKL levels were also higher in ACPA positive patients than ACPA negative. Our study found a correlation between RANKL levels and some parameters: DAS28, ACPA, CRP, and symptom duration. There was a moderate inverse correlation between RANKL levels and BMD. By ROC curve, our results displayed that the best cut-off value of RANKL was 178.99 pg/ml (sensitivity 79.31%; specificity 90%) to differentiate between RA patients and controls. In conclusion, elevated serum RANKL can be used as an indicator of disease activity and a diagnostic new biomarker in patients with early RA.
ABSTRACT

 



عداد الزوار / 684144 /